Representation of a publicly traded real estate company in connection with its build-to-suit development, construction and sale of a 50,000 square-foot building to an international pharmaceutical company. The representation involved contractual, land use, construction and due diligence issues.
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.
